US 7,510,735 B2
	Method of evaluating the extent of reaching the intestine of bifidobacterium in fermented milk food or drink
Yasuhisa Shimakawa, Tokyo (Japan); Masaki Serata, Tokyo (Japan); Hirokazu Tsuji, Tokyo (Japan); Koichiro Sonoike, Tokyo (Japan); Akimitsu Takagi, Tokyo (Japan); Mika Miura, Tokyo (Japan); and Fumiyasu Ishikawa, Tokyo (Japan)
Assigned to Kabushiki Kaisha Yakult Honsha, Tokyo (Japan)
Appl. No. 10/470,776 PCT Filed Dec. 21, 2001, PCT No. PCT/JP01/11266 § 371(c)(1), (2), (4) Date Jul. 31, 2003, PCT Pub. No. WO02/061118, PCT Pub. Date Aug. 08, 2002.
Claims priority of application No. 2001-025297 (JP), filed on Feb. 01, 2001.
Prior Publication US 2004/0052902 A1, Mar. 18, 2004
Int. Cl. A23C 9/12 (2006.01); A23C 17/00 (2006.01)

U.S. Cl. 426—42  [435/4]

9 Claims

1. An isolated Bifidobacterium breve strain exhibiting viability of 20% or greater after treatment in an acid treatment solution at pH 4.3 at 37° C. for 30 minutes, followed by treatment in a bile treatment solution containing 1% bile at 37° C. for 30 minutes compared to the same strain prior to said acid and bile treatments.